menu
    • menu

    Company profile for JW Therapeutics

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    JW Therapeutics aims to revolutionize cancer treatment by building the best and most innovative cell-therapy company. We are committed to the development, transformation and promotion of breakthrough cell-based immunotherapies to save the lives of cancer patients, improving their quality of life and bringing them a new hope. JW Therapeutics (Shanghai) Co., Ltd will leverage Juno’s expertise in cell therapy technologies a...
    JW Therapeutics aims to revolutionize cancer treatment by building the best and most innovative cell-therapy company. We are committed to the development, transformation and promotion of breakthrough cell-based immunotherapies to save the lives of cancer patients, improving their quality of life and bringing them a new hope. JW Therapeutics (Shanghai) Co., Ltd will leverage Juno’s expertise in cell therapy technologies and WuXi AppTec’s excellence in contract services, and collaborate broadly with Chinese medical communities and government regulators to develop cell therapies that will deliver cutting-edge cancer treatments.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    JW TherapeuticsChina Flag
    Country
    Country
    China
    Address
    Address
    2F-B, No.227, Meisheng Rd. Pilot Free Trade Zone, Shanghai
    Telephone
    Telephone
    + 86-21-50464201
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.jwtherapeutics.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Imugene, JW Therapeutics Collaborate Oncarlytics & Carteyva
    Imugene, JW Therapeutics Collaborate Oncarlytics & Carteyva

    01 Dec 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/imugene-and-jw-therapeutics-announce-a-collaboration-to-advance-oncarlytics-and-carteyva-combination-in-solid-tumours-302627893.html

    PR NEWSWIRE
    01 Dec 2025
    Share Share
    JW Gets Carteyva Breakthrough Tag for B-cell Lymphoma in China
    JW Gets Carteyva Breakthrough Tag for B-cell Lymphoma in China

    11 Jan 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/jw-therapeutics-announces-receipt-of-breakthrough-therapy-designation-for-carteyva-in-china-as-second-line-treatment-in-relapsed-or-refractory-adult-large-b-cell-lymphoma-302347802.html

    PR NEWSWIRE
    11 Jan 2025
    Share Share
    Medigene Receives Milestone Payment from Regeneron Pharma, Inc.
    Medigene Receives Milestone Payment from Regeneron Pharma, Inc.

    03 Dec 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/12/03/2990360/0/en/Medigene-Receives-Milestone-Payment-from-Regeneron-Pharmaceuticals-Inc.html

    GLOBENEWSWIRE
    03 Dec 2024
    Share Share
    JW Therapeutics Announces NMPA Approval For Carteyva In Lymphoma Patients
    JW Therapeutics Announces NMPA Approval For Carteyva In Lymphoma Patients

    27 Aug 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/jw-therapeutics-announces-nmpa-approval-of-the-supplemental-biological-license-application-for-carteyva-in-adult-patients-with-relapsed-or-refractory-mantle-cell-lymphoma-302231445.html

    PR NEWSWIRE
    27 Aug 2024
    Share Share
    Relma-Cel Data In Lupus Patients Presented At Eular 2024 Congress
    Relma-Cel Data In Lupus Patients Presented At Eular 2024 Congress

    30 May 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/preliminary-clinical-data-on-relma-cel-injection-in-adults-with-active-systemic-lupus-erythematosus-in-china-at-the-eular-2024-congress-302159238.html

    PR NEWSWIRE
    30 May 2024
    Share Share
    JW Therapeutics Announces IND Approval for the Clinical Trial of Relma-cel
    JW Therapeutics Announces IND Approval for the Clinical Trial of Relma-cel

    10 Apr 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/jw-therapeutics-announces-ind-approval-for-the-clinical-trial-of-relma-cel-in-patients-with-moderately-or-severely-refractory-systemic-lupus-erythematosus-301793059.html

    PR NEWSWIRE
    10 Apr 2023
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search